Prof. Dr Lothar H. Wieler

Prof. Dr Lothar H. Wieler is President of the Robert Koch Institute in Berlin. From 1998 to 2015 he was University Professor for Microbiology and Animal Disease Studies at the Freie Universität Berlin. His research focuses on the “One Health” approach with an emphasis on zoonoses (diseases that are transmitted between animals and humans). In his research, he is interested in the molecular mechanisms that enable bacterial zoonotic pathogens to infect different hosts. His focus is on antibiotic-resistant and multi-resistant bacteria. Lothar Wieler is the author of over 250 scientific publications and has received several scientific prizes. He is co-founder of the German Research Platform for Zoonoses, and Deputy Spokesman of the InfectControl 2020 project consortium, which researches trans-sectoral approaches to infection prophylaxis and intervention in the “One Health” approach. He is also, among other posts, a member of the STAG-IH (Strategic and Technical Advisory Group for Infectious Hazards) of the World Health Organization, the EACHR (WHO Europe Advisory Committee on Health Research), and member of the advisory board of Technology, Methods, and Infrastructure for Networked Medical Research (TMF). He is the spokesman for the InfectControl2020 consortia IRMRESS (innovative reduction of multi-resistant infectious agents [MRE] and establishment of a next-generation sequencing-based molecular surveillance) and Neobiom (factors influencing the development of micro-, resistor- and mycobiome in premature infants). Before that, Wieler was the spokesman for the BMBF joint project FBI-Zoo (Foodborne Zoonotic Infections in Humans) and the International DFG Research Training Group 1673 (Functional Molecular Infection Epidemiology). Since 2010 Wieler has been an elected member of the German National Academy of Sciences Leopoldina, where he has served as a Senator since 2016.


Convoco gemeinnützige Stiftung-GmbH

Zur Förderung der Wissenschaft und Bildung

Brienner Str. 28
80333 Munich


Sign up now for exclusive news. We will use your personal information as described in our privacy policy.

© 2024. All Rights Reserved